Pacira BioSciences, Inc. (PCRX) total debt

Total debt · fiscal 2025
$418.20M

Pacira BioSciences, Inc. (PCRX) carried total debt of $418.20M at the end of fiscal 2025 (December 31, 2025). That is 34.5% lower than the $638.85M of fiscal 2024. Figures as of 18 Nov 2026, 12:19 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Total debt, fiscal 2025
$418.20M
Change on fiscal 2024
−34.5%
Growth, 10 years
+6.5% a year
Highest on record
$763.39Mfiscal 2022
Lowest on record
$25.05Mfiscal 2010
Fiscal years on record
112010–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Pacira BioSciences, Inc. total debt, in more detail

Over the ten fiscal years to 2025 total debt grew at a compound 6.5% a year. Across the 11 fiscal years on record (2010–2025), the highest was $763.39M in fiscal 2022 and the lowest $25.05M in fiscal 2010.

Total debt was 0.6× shareholders' equity at the end of fiscal 2025.

History · 11 fiscal years

Total debt by fiscal year

Pacira BioSciences, Inc. total debt, year by year

Pacira BioSciences, Inc. (PCRX) total debt by fiscal year
Fiscal yearTotal debtChangeYear endedDebt ÷ equity
2025$418.20M 34.5% down0.6×
2024$638.85M 9.0% up0.8×
2023$586.04M 23.2% down0.7×
2022$763.39M—1.0×
2016$227.27M 2.1% up1.0×
2015$222.57M 0.2% down1.0×
2014$223.10M 85.9% up1.3×
2013$120.00M 376.4% up2.9×
2012$25.19M 1.5% down0.4×
2011$25.58M 2.1% up0.5×
2010$25.05M——

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Total debt adds the short-term and long-term borrowings on the balance sheet at the fiscal year-end; debt-to-equity divides it by shareholders' equity and is left blank when equity is negative.

How to read it

Debt magnifies results in both directions — set it against cash, equity and the profit available to pay the interest rather than reading it alone.

More on PCRX

Pacira BioSciences, Inc., figure by figure

Pacira BioSciences, Inc. (PCRX) overview: price, valuation and scorecard

Pacira BioSciences, Inc. total debt: questions and answers

How much debt does Pacira BioSciences, Inc. have?

Pacira BioSciences, Inc. (PCRX) carried total debt of $418.20M at the end of fiscal 2025 (December 31, 2025). That is 34.5% lower than the $638.85M of fiscal 2024.

What is the growth rate of Pacira BioSciences, Inc.'s total debt?

Over the ten fiscal years to 2025 total debt grew at a compound 6.5% a year.

What are the highest and lowest total debt figures on record for Pacira BioSciences, Inc.?

Across the 11 fiscal years on record (2010–2025), the highest was $763.39M in fiscal 2022 and the lowest $25.05M in fiscal 2010.

How does Pacira BioSciences, Inc.'s debt compare with its equity?

Total debt was 0.6× shareholders' equity at the end of fiscal 2025.

How is Pacira BioSciences, Inc.'s total debt calculated?

Total debt adds the short-term and long-term borrowings on the balance sheet at the fiscal year-end; debt-to-equity divides it by shareholders' equity and is left blank when equity is negative. For Pacira BioSciences, Inc. it is on record here for 11 fiscal years, 2010 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Pacira BioSciences, Inc. (PCRX) total debt”, data as of 18 November 2026. https://funkfolio.com/stock/PCRX/total-debt

Underlying data: the company's filings with the SEC and Yahoo Finance.